Pra Health Sciences Inc Price to Earnings Ratio (PE) Ratios, (PRAH) Valuation Ranking and Trends, Fundamental Ratios - CSIMarket
CSIMarket
 




Pra Health Sciences Inc   (NASDAQ: PRAH)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 





PRAH Price to Earnings Ratio Current (Dec 31 2020) (Sep 30 2020) (Jun 30 2020) (Mar 31 2020)
Diluted EPS 12 Trailing Months IV. Quarter III. Quarter II. Quarter I. Quarter
PE (TTM) Ratio current            50.37            36.67            30.08            28.81            26.87
Diluted EPS TTM Y / Y Change -9.64 % -16.67 % -6.09 % 35.71 % 51.25 %
Diluted EPS Y / Y Change 36.51 % -30.09 % 12.8 % -64.52 % -4.55 %
Stock performance to date 33.85 % 19.34 % 6.87 % 27.59 % -24.58 %

Price to earnings ratio Comment
Pra Health Sciences Inc 's current Price to earnings ratio has increased due to shareprice growth of 33.85 %, from beginning of I. Quarter and despite eps increase of 36.51 %, to Pe of 50.37, from average Price to earnings ratio in IV. Quarter of 36.67.

Within Healthcare sector 199 other companies have lower Price to earnings ratio.

What is Price to Earnings Ratio?
What is Pra Health Sciences Inc Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #8
Sector #200
S&P 500 #2231





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.